| This week's sponsor is Premier Research. | | | 7 Things to Watch When Recruiting for an Opioid Trial
Recruiting for an opioid trial? Consider seven key factors, such as avoiding drug abuse and diversion and minimizing screen failures. Find the details here. Premier Research. It's what we do. Best. |
Today's Rundown Biogen bags Karyopharm neurological drug in $217M deal British newco KaNDy Therapeutics said to be in Allergan M&A crosshairs Shanghai Pharma seeking deals to drive overseas expansion Synpromics, UCL ally to aim gene therapies at blood-based diseases Takeda, Zinfandel ax Alzheimer’s test for pioglitazone, chalking up another AD fail Summit Therapeutics unveils encouraging early data for Duchenne drug China AI biotech XtalPi lands $15M from Sequoia, Google, Tencent Spark, Novartis tie up in gene therapy licensing deal worth up to $170M Featured Story | | | Thursday, January 25, 2018 Biogen has added Karyopharm’s KPT-350 to its pipeline. The big biotech is paying $10 million upfront and committing to up to $207 million more in milestones to buy the IND-ready oral SINE compound and related, earlier-stage assets. |
|
|
Top Stories Thursday, January 25, 2018 Allergan, flush from a series of small and midsized deals over the past 18 months, is reported to be seeking a buyout of women’s health company KaNDy Therapeutics. Thursday, January 25, 2018 China’s Shanghai Pharma is planning to open an R&D unit in San Diego as part of an international expansion drive that could also include acquisitions in the U.S. and Europe, according to media reports. Thursday, January 25, 2018 Synpromics has entered into another gene therapy collaboration with UCL. This time around the aim is to apply Synpromics’ synthetic promoter expertise to the development of gene therapies against diseases affecting blood production. Thursday, January 25, 2018 Japanese Big Pharma Takeda and U.S. partner Zinfandel Pharmaceuticals have decided to give up and stop testing a 20-year-old diabetes medicine that they hoped could work as a new Alzheimer’s therapy. Thursday, January 25, 2018 At 24 weeks, Summit's ezutromid raised utrophin levels and reduced muscle damage in a phase 2 trial. If the trend continues, the utrophin modulator has the potential to become a wider, disease-modifying treatment for the muscle-wasting disease. Thursday, January 25, 2018 As capital continues to pile onto applications of artificial intelligence in drug R&D, XtalPi, a Chinese startup working in that field, has secured a $15 million series B backed by high-profile tech investors Sequoia China, Google and Chinese internet giant Tencent. Thursday, January 25, 2018 Intent to focus on the first-ever gene therapy launch in the U.S., Spark Therapeutics has licensed voretigene neparvovec to Novartis in all other markets. | This week's sponsor is IQVIA. | | | Discover a new path to your success via Human Data Science. IMS Health and Quintiles are now IQVIA™ – created to advance your pursuits of human science by unleashing the power of data science and human ingenuity. Join the journey today. Learn More. |
Enrollment Showcase | | | Sponsored by: Drexel University Online Drexel University’s online graduate programs in biomedicine, clinical research, drug discovery, and molecular medicine were developed with working professionals in mind, providing you with the education, practical skills, and competitive edge you need to be successful in your career. Learn more. |
|
|
Resources Sponsored by: Agilent This Agilent intact protein analysis includes: Sponsored by: Seton Hall Don’t miss this educational program trusted by multi-national companies as part of their employee’s compliance training. Explore legal, regulatory and ethical issues faced by pharmaceutical, biotech and medical device manufacturers operating in the Asia-Pacific region. Visit event page for session topics. Presented by: Patheon Download Patheon’s whitepaper to discover two main areas where a drug developer can face significant obstacles during biologics development and how by evaluating these capabilities, it can answer the critical question of whether its in-house strategy is ready for these uncertainties. Presented by: SDC and Stiris Research What do you do when timelines are missed, data is dirty, and everyone is pointing fingers? Join this webinar to learn how to prevent, identify, and implement a successful clinical trial rescue. Sponsored by: Veeva Systems Expanding into new markets places a spotlight on inefficient processes. Sponsored by: Veeva Systems Regulatory leaders share challenges and best practices from a lack of standardization, manual processes, and fragmented systems. Sponsored by: WCG Selecting the right sites to conduct your clinical trials will determine the success or failure of meeting your enrollment goals. Sponsored by: Veeva Systems Read this guide if you’re a global life sciences company - conducting clinical trials across several countries, or manufacturing and distributing products in multiple regions - to learn five steps to align and improve quality oversight, as well as avoid common mistakes in harmonization initiatives. Presented By: Covance Global clinical trials are the trend and gaining in popularity, but running a global trial is not a straightforward process. This white paper explores some of the challenges associated with global clinical trials and considerations for ensuring that the collected data comply with the trial's overall objectives. Presented By: Charles River Join us as we discuss how Charles River Celsis® helped Labor L+S AG validate a 7-day membrane filtration sterility test using existing protocols. Presented By: Catalent Learn how Catalent Biologics is paving the way for flexible biologics development and manufacturing through advanced technologies and fully integrated multi-product facility. Presented By: Catalent Download the eBook to get articles from various Elsevier journals highlighting developments in ADC technology. Presented By: Catalent Learn how cell development and process scale-up can be optimized for antibodies requiring additional processing. Sponsored By: RTI Health Solutions In this webinar, we will introduce the rapidly-evolving within-subject clinical trial (WSCT) methods for early phase evidence generation that require fewer people, less time, and usually less funding than traditional early phase methods. Drug Approval, Manufacturing Quality & Regulation 2018 | Online TMF Operations: a Quality and Regulatory Approach March 19 - 21, 2018 | Berlin, Germany
Drug Development Boot Camp® 2018 November 14-15, 2018 | Boston, MA ICI Boston Summit 2018 March 19-21, 2018 | Boston, MA MIXiii-Biomed 2018 May 15-17, 2018 | Tel-Aviv, Israel Field Service Medical February 26-28, 2018 | Hilton La Jolla, Torrey Pines, CA | 